OSCR Oscar Health, Inc. Class A Common Stock
O Oscar Health, Inc. Class A Common Stock Przegląd firmy z Wikipedii
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
Czytaj więcej
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.
History
2012–2015
According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Joshua and his brother Jared owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.
2016
Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".
In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."
2017
On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.
On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.
A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Joshua's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.
While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.
2020–present
In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."
As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."
Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.
Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.
Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO. [1]
In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.
Marketing and brand
Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".
In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.
In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.
Finances
Funding
Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.
During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.
During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.
In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.
During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.
In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.
Revenue
In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.
Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."
By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.
In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.
In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.
In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.
In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.
Headquarters and offices
Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
OSCR Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
OSCR Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
OSCR Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 2 10,5%
- Kup 7 36,8%
- Trzymaj 9 47,4%
- Sprzedaj 1 5,3%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
10 analityków · 2026-08-15Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $1.10 | $0.39 | 0.71% |
| 31 marca 2026 | $2.07 | $1.21 | 0.86% |
| 31 grudnia 2025 | $-1.24 | $-0.91 | -0.33% |
| 30 września 2025 | $-0.53 | $-0.57 | 0.04% |
| 30 czerwca 2025 | $-0.89 | $-0.47 | -0.42% |
| 31 marca 2025 | $0.92 | $0.81 | 0.11% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| OSCR | — | -8.5 | 27.5% | -3.8% | -44.5% | — |
| PRU | — | — | — | — | — | — |
| PFG | $19.18B | 16.8 | -3.1% | 7.6% | 10.3% | — |
| UNM | — | — | — | — | — | — |
| GL | $12.90B | 9.9 | 3.7% | 19.4% | 20.4% | — |
| PRI | $8.22B | 11.3 | 6.6% | 22.8% | 31.9% | — |
| LNC | $8.46B | 7.6 | -1.2% | 6.5% | 12.3% | — |
| CNO | $4.01B | 18.5 | 0.85% | 5.1% | 8.9% | — |
| GNW | $3.54B | 16.7 | 0.08% | 3.0% | 2.6% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $463M | |
| SG&A Expense | $2.05B | $1.76B | $1.43B | $1.26B | $265M | $167M | |
| Operating Income | $-396M | $57M | $-236M | $-590M | $-544M | $-402M | |
| Interest Expense | · | · | $25M | $23M | $5M | $4M | |
| Other Non-op | $-23M | $-105.0K | $-7M | $2M | $-1M | · | |
| Pretax Income | $-437M | $33M | $-267M | $-610M | $-571M | $-406M | |
| Income Tax | $6M | $7M | $3M | $-523.0K | $846.0K | $1M | |
| Net Income | $-443M | $25M | $-271M | $-606M | $-573M | $-407M | |
| EPS (Basic) | $-1.69 | $0.11 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| EPS (Diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 | |
| Shares (Basic) | 262,388,000 | 240,386,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| Shares (Diluted) | 262,388,000 | 265,853,000 | 221,655,000 | 212,475,000 | 178,967,056 | 29,263,424 | |
| EBITDA | $-367M | $89M | $-205M | · | $-530M | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826M | |
| Short-term Investments | · | $624M | $690M | · | · | · | |
| Receivables | $363M | · | · | · | · | · | |
| Other Current Assets | $24M | $21M | $7M | $6M | $4M | · | |
| Current Assets | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B | |
| PP&E (Net) | $88M | $67M | $62M | $60M | $47M | $36M | |
| PP&E (Gross) | $230M | $181M | $150M | $117M | $89M | $63M | |
| Accum. Depreciation | $142M | $114M | $88M | $57M | $42M | $27M | |
| Other Non-current Assets | $120M | $82M | $83M | $95M | $97M | $13M | |
| Total Assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B | |
| Accounts Payable | $507M | $432M | $273M | $298M | $235M | $138M | |
| Current Liabilities | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B | |
| Capital Leases | $52M | $61M | $67M | $72M | $77M | · | |
| Other Non-current Liabilities | $52M | $61M | $68M | $72M | $77M | $0 | |
| Total Liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B | |
| Total Debt | $430M | $300M | $299M | · | $0 | · | |
| Common Stock | · | · | · | · | · | $2.0K | |
| Paid-in Capital | $4.26B | $3.87B | $3.68B | $3.51B | $3.39B | $133M | |
| Retained Earnings | $-3.29B | $-2.85B | $-2.88B | $-2.61B | $-2.00B | $-1.43B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | |
| AOCI | $18M | $-2M | $1M | $-10M | $-4M | $879.0K | |
| Stockholders' Equity | $978M | $1.01B | $804M | $890M | $1.39B | $-1.30B | |
| Liabilities + Equity | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $29M | $32M | $31M | $15M | $15M | $11M | |
| Stock-based Comp | $88M | $110M | $160M | $112M | $86M | $36M | |
| Deferred Tax | $2M | $-2M | $58.0K | $-165.0K | $-101.0K | $-67.0K | |
| Other Non-cash | $1.42B | $813M | $-192M | · | $290M | · | |
| Operating Cash Flow | $1.09B | $978M | $-272M | $380M | $-182M | $223M | |
| CapEx | $36M | $28M | $26M | $29M | $26M | $14M | |
| Investing Cash Flow | $-241M | $-1.39B | $577M | $-227M | $-775M | $-345M | |
| Debt Issued | $410M | $0 | $0 | $305M | $0 | $147M | |
| Net Debt Issued | $410M | $0 | $0 | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | |
| Financing Cash Flow | $399M | $68M | $6M | $301M | $1.24B | $612M | |
| Net Change in Cash | $1.25B | $-341M | $311M | $455M | $282M | $490M | |
| Taxes Paid | $18M | $674.0K | $2M | $2M | $697.0K | $2M | |
| Free Cash Flow | $1.06B | $950M | $-298M | · | $-208M | · | |
| Levered FCF | · | · | $-323M | · | $-212M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4% | 0.62% | -4.0% | · | -29.6% | · | |
| Net Margin | -3.8% | 0.28% | -4.6% | · | -31.1% | · | |
| Pretax Margin | -3.7% | 0.36% | -4.6% | · | -31.0% | · | |
| EBITDA Margin | -3.1% | 0.97% | -3.5% | · | -28.8% | · | |
| ROA | -7.9% | 0.60% | -6.7% | · | -20.5% | · | |
| ROE | -44.5% | 2.8% | -32.0% | · | -36.7% | · | |
| ROIC | -28.5% | 3.4% | -21.6% | · | -39.3% | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | 1.3 | · | 1.2 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | · | 0.6 | · | |
| Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| LT Debt / Equity | 0.4 | 0.3 | 0.4 | · | 0.0 | · | |
| Interest Coverage | · | · | -9.6 | · | -115.4 | · |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.1 | 2.2 | 1.4 | · | 0.7 | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.5% | 56.5% | 47.9% | 115.6% | 297.3% | · | |
| Revenue CAGR 3Y | 43.5% | 70.9% | 133.1% | · | · | · | |
| Revenue CAGR 5Y | 90.8% | · | · | · | · | · |
Wycena (TTM) 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | · | |
| Net Income TTM | $-443M | $25M | $-271M | $-606M | $-573M | · | |
| P/E | -8.5 | 134.4 | -7.5 | -0.9 | -2.5 | · | |
| Earnings Yield | -11.8% | 0.74% | -13.3% | -115.9% | -40.8% | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B | $1.52B | $1.47B | $995M | $978M | |
| SG&A Expense | $691M | $706M | $511M | $522M | $534M | $483M | $466M | $460M | $435M | $394M | $364M | $326M | $337M | $399M | $1.02B | $79M | |
| Operating Income | $389M | $704M | $-334M | $-129M | $-230M | $297M | $-148M | $-48M | $68M | $186M | $-145M | $-58M | $-7M | $-25M | $-222M | $-192M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | |
| Other Non-op | $-915.0K | $71.0K | $-20M | $-3M | $3M | $-3M | $68.0K | $2M | $-872.0K | $-1M | $1M | $-414.0K | $-2M | $-6M | $1M | $3M | |
| Pretax Income | $383M | $699M | $-353M | $-139M | $-234M | $288M | $-154M | $-52M | $61M | $178M | $-151M | $-65M | $-14M | $-38M | $-227M | $-195M | |
| Income Tax | $21M | $20M | $-247.0K | $-2M | $-5M | $13M | $-404.0K | $2M | $5M | $996.0K | $-806.0K | $915.0K | $1M | $2M | $-715.0K | $-2M | |
| Net Income | $362M | $679M | $-353M | $-137M | $-228M | $275M | $-154M | $-55M | $56M | $177M | $-150M | $-65M | $-16M | $-40M | $-226M | $-193M | |
| EPS (Basic) | $1.20 | $2.28 | $-1.37 | $-0.53 | $-0.89 | $1.10 | $-0.68 | $-0.22 | $0.24 | $0.77 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| EPS (Diluted) | $1.10 | $2.07 | $-1.19 | $-0.53 | $-0.89 | $0.92 | $-0.50 | $-0.22 | $0.20 | $0.62 | $-0.68 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | |
| Shares (Basic) | 302,220,000 | 298,184,000 | -503,695,000 | 259,273,000 | 255,531,000 | 251,279,000 | -472,835,000 | 243,106,000 | 238,672,000 | 231,443,000 | -437,757,000 | 223,099,000 | 219,400,000 | 216,913,000 | -422,206,923 | 212,822,733 | |
| Shares (Diluted) | 333,432,000 | 329,751,000 | -558,354,000 | 259,273,000 | 255,531,000 | 305,938,000 | -575,014,000 | 243,106,000 | 303,965,000 | 293,796,000 | -437,757,000 | 223,099,000 | 219,400,000 | 216,913,000 | -422,206,923 | 212,822,733 | |
| EBITDA | $389M | $711M | · | $-129M | $-230M | $304M | · | $-48M | $68M | $193M | · | $-58M | $-7M | $-20M | · | $-192M |
Bilans 21
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B | $1.21B | $2.27B | $2.23B | $1.87B | $1.40B | $2.32B | $2.11B | $1.56B | $2.11B | |
| Receivables | $380M | $587M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $60M | $26M | $24M | $29M | $30M | $23M | $21M | $21M | $16M | $9M | · | $8M | $8M | $11M | · | $16M | |
| Current Assets | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B | $2.37B | $3.36B | $3.50B | · | $2.99B | $4.19B | $4.13B | · | $3.93B | |
| PP&E (Net) | $101M | $94M | $88M | $83M | $78M | $72M | $67M | $67M | $64M | $61M | · | $62M | $63M | $64M | · | $56M | |
| PP&E (Gross) | · | · | $230M | · | · | · | $181M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $142M | · | · | · | $114M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $122M | $123M | $120M | $121M | $116M | $94M | $82M | $84M | $87M | $87M | · | $89M | $92M | $95M | · | $97M | |
| Total Assets | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B | |
| Accounts Payable | $526M | $506M | $650M | $557M | $584M | $634M | $432M | $395M | $348M | $303M | · | $260M | $262M | $299M | · | $252M | |
| Current Liabilities | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B | $2.95B | $3.50B | $3.02B | · | $2.06B | $3.24B | $3.18B | · | $2.85B | |
| Capital Leases | · | · | $52M | · | · | · | $61M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $50M | $51M | $52M | $56M | $57M | $59M | $61M | $64M | $65M | $66M | · | $69M | $70M | $71M | · | $74M | |
| Total Liabilities | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B | $3.32B | $3.87B | $3.38B | · | $2.43B | $3.61B | $3.55B | · | $3.22B | |
| Total Debt | $432M | $431M | · | $686M | $300M | $300M | · | $299M | $299M | $299M | · | $299M | $298M | $298M | · | $298M | |
| Paid-in Capital | $4.32B | $4.28B | $4.26B | $3.95B | $3.95B | $3.90B | $3.87B | $3.84B | $3.79B | $3.74B | · | $3.65B | $3.62B | $3.58B | · | $3.48B | |
| Retained Earnings | $-2.25B | $-2.62B | $-3.29B | $-2.94B | $-2.80B | $-2.58B | $-2.85B | $-2.70B | $-2.64B | $-2.70B | · | $-2.73B | $-2.66B | $-2.65B | · | $-2.38B | |
| Treasury Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| AOCI | $-8M | $5M | $18M | $16M | $14M | $10M | $-2M | $26M | $-3M | $-3M | · | $-4M | $-7M | $-4M | · | $-14M | |
| Stockholders' Equity | $2.05B | $1.66B | $978M | $1.02B | $1.16B | $1.33B | $1.01B | $1.16B | $1.14B | $1.03B | · | $919M | $950M | $930M | · | $1.08B | |
| Liabilities + Equity | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B | $4.48B | $5.01B | $4.42B | · | $3.35B | $4.56B | $4.48B | · | $4.31B |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $7M | $8M | $7M | $7M | $7M | $9M | $8M | $8M | $8M | $8M | $9M | $9M | $5M | $4M | $4M | |
| Stock-based Comp | $21M | $16M | $18M | $20M | $24M | $25M | $26M | $29M | $29M | $26M | $26M | $29M | $33M | $71M | $29M | $29M | |
| Deferred Tax | $-2M | $-6M | $3M | $-175.0K | $-36.0K | $36.0K | $-2M | $-119.0K | $130.0K | $-79.0K | $-37.0K | $69.0K | $209.0K | $-183.0K | $-171.0K | $2.0K | |
| Other Non-cash | · | $1.92B | · | · | · | $572M | · | · | · | $423M | · | · | · | $378M | · | · | |
| Operating Cash Flow | $2.09B | $2.62B | $672M | $-965M | $509M | $879M | $347M | $-500M | $497M | $634M | $297M | $-1.15B | $166M | $415M | $151M | $-548M | |
| CapEx | $12M | $9M | $9M | $9M | $9M | $9M | $7M | $8M | $8M | $6M | $6M | $6M | $6M | $7M | $7M | $10M | |
| Investing Cash Flow | $-2.83B | $-590M | $-49M | $150M | $-168M | $-174M | $-31M | $-578M | $-478M | $-301M | $172M | $225M | $44M | $136M | $-707M | $299M | |
| Debt Issued | · | · | $0 | · | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $13M | $-4M | $8M | $364M | $22M | $5M | $4M | $19M | $19M | $27M | $1M | $2M | $3M | $506.0K | $527.0K | $423.0K | |
| Net Change in Cash | $-729M | $2.03B | $631M | $-451M | $363M | $709M | $319M | $-1.06B | $38M | $361M | $470M | $-922M | $212M | $551M | $-555M | $-249M | |
| Taxes Paid | $1M | $44.0K | $19.0K | $2M | $15M | $0 | $38.0K | $552.0K | · | · | $1M | $600.0K | · | · | $233.0K | $555.0K | |
| Free Cash Flow | · | $2.61B | · | · | · | $870M | · | · | · | $628M | · | · | · | $407M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $623M | · | · | · | $401M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 8.0% | 15.2% | · | -4.3% | -8.1% | 9.8% | · | -2.0% | 3.1% | 8.7% | · | -4.0% | -0.43% | -1.7% | · | -19.7% | |
| Net Margin | 7.4% | 14.6% | · | -4.6% | -8.0% | 9.0% | · | -2.2% | 2.5% | 8.3% | · | -4.5% | -1.0% | -2.7% | · | -19.7% | |
| Pretax Margin | 7.8% | 15.0% | · | -4.7% | -8.2% | 9.5% | · | -2.2% | 2.8% | 8.3% | · | -4.5% | -0.94% | -2.6% | · | -20.0% | |
| EBITDA Margin | 8.0% | 15.3% | · | -4.3% | -8.1% | 10.0% | · | -2.0% | 3.1% | 9.0% | · | -4.0% | -0.43% | -1.4% | · | -19.7% | |
| ROA | 4.1% | 9.0% | · | -2.7% | -4.0% | 5.4% | · | -1.4% | 1.2% | 4.0% | · | -1.7% | -0.33% | -0.90% | · | -5.2% | |
| ROE | 22.5% | 45.3% | · | -12.6% | -19.9% | 23.3% | · | -5.2% | 5.4% | 18.1% | · | -6.5% | -1.4% | -3.5% | · | -14.6% | |
| ROIC | 14.8% | 32.7% | · | -7.5% | -15.5% | 17.4% | · | -3.4% | 4.4% | 13.9% | · | -4.9% | -0.57% | -2.2% | · | -13.8% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 1.0 | 1.2 | · | 1.5 | 1.3 | 1.3 | · | 1.4 | |
| Quick Ratio | 0.5 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| LT Debt / Equity | 0.2 | 0.3 | · | 0.7 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 31.4 | · | -9.5 | -1.1 | -4.1 | · | -31.4 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 25.7 | 15.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.38B | $13.54B | · | $11.32B | $10.55B | $9.83B | · | $8.23B | $7.32B | $6.57B | · | $5.41B | $4.99B | $4.44B | · | $3.41B | |
| Net Income TTM | $675M | $588M | · | $-145M | $49M | $454M | · | $114M | $153M | $57M | · | $-314M | $-360M | $-420M | · | $-592M | |
| P/E | 16.3 | 7.3 | · | -26.3 | 2144.0 | 8.6 | · | 68.4 | 34.4 | 185.9 | · | -3.8 | -4.8 | -3.3 | · | -1.8 | |
| Earnings Yield | 6.1% | 13.7% | · | -3.8% | 0.05% | 11.6% | · | 1.5% | 2.9% | 0.54% | · | -26.0% | -21.0% | -30.3% | · | -56.5% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| Marża Operacyjna % | -3.4% | 0.62% | -4.0% | — | -29.6% |
| Zysk netto | $-443M | $25M | $-271M | $-606M | $-573M |
| Rozwodniony EPS | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.4 | 0.3 | 0.4 | — | 0.0 |
| Wskaźnik bieżący | 0.9 | 0.8 | 1.3 | — | 1.2 |
| Wskaźnik Szybkości | 0.6 | 0.6 | 0.8 | — | 0.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.06B | $950M | $-298M | — | $-208M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 462 emitenci · $4.5B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 133 (+65 vs poprzedni kw.) | 45 (-20 vs poprzedni kw.) | 140 (+17 vs poprzedni kw.) | 107 (-3 vs poprzedni kw.) | +39.9M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $314 559 172 | 11 029 424 | 7,02% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $301 725 543 | 10 579 437 | 6,73% | Akcje |
| D. E. Shaw & Co., Inc. | $259 880 743 | 9 112 228 | 5,80% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $258 255 502 | 9 055 242 | 5,76% | Akcje |
| Thrive Capital Management, LLC | $180 919 957 | 6 343 617 | 4,04% | Akcje |
| STATE STREET CORP | $165 454 531 | 5 801 351 | 3,69% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $162 917 648 | 5 712 400 | 3,64% | Opcja kupna |
| GEODE CAPITAL MANAGEMENT, LLC | $141 980 956 | 4 977 203 | 3,17% | Akcje |
| FMR LLC | $138 622 458 | 4 860 535 | 3,09% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $115 097 850 | 4 035 689 | 2,57% | Akcje |
| BIT Capital GmbH | $97 480 134 | 3 417 957 | 2,18% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $94 434 740 | 3 311 177 | 2,11% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $93 673 940 | 3 284 500 | 2,09% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $86 282 012 | 3 025 316 | 1,93% | Akcje |
| JANE STREET GROUP, LLC | $74 631 792 | 2 616 823 | 1,67% | Akcje |
| GLYNN CAPITAL MANAGEMENT LLC | $73 462 615 | 2 575 828 | 1,64% | Akcje |
| CITADEL ADVISORS LLC | $72 469 320 | 2 541 000 | 1,62% | Opcja kupna |
| WOLVERINE ASSET MANAGEMENT LLC | $61 825 656 | 2 167 800 | 1,38% | Opcja sprzedaży |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60 458 493 | 2 119 863 | 1,35% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55 351 616 | 1 940 800 | 1,24% | Opcja sprzedaży |
| JANE STREET GROUP, LLC | $53 968 396 | 1 892 300 | 1,20% | Opcja kupna |
| BlackBarn Capital Partners LP | $49 910 000 | 1 750 000 | 1,11% | Opcja sprzedaży |
| BNP PARIBAS FINANCIAL MARKETS | $48 660 710 | 1 706 196 | 1,09% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $45 996 029 | 1 612 764 | 1,03% | Akcje |
| CITADEL ADVISORS LLC | $44 459 828 | 1 558 900 | 0,99% | Opcja sprzedaży |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $41 354 000 | 1 450 000 | 0,92% | Akcje |
| BANK OF AMERICA CORP /DE/ | $36 176 793 | 1 268 471 | 0,81% | Akcje |
| Assenagon Asset Management S.A. | $35 592 732 | 1 247 992 | 0,79% | Akcje |
| TWO SIGMA ADVISERS, LP | $35 534 136 | 2 472 800 | 0,79% | Akcje |
| JANE STREET GROUP, LLC | $33 796 200 | 1 185 000 | 0,75% | Opcja sprzedaży |
| GROUP ONE TRADING LLC | $32 744 154 | 1 148 112 | 0,73% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $31 200 652 | 1 093 992 | 0,70% | Akcje |
| Qube Research & Technologies Ltd | $30 913 940 | 1 083 939 | 0,69% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $29 055 948 | 1 018 792 | 0,65% | Akcje |
| GILDER GAGNON HOWE & CO LLC | $28 576 515 | 1 001 982 | 0,64% | Akcje |
| GOLDMAN SACHS GROUP INC | $26 322 819 | 922 960 | 0,59% | Akcje |
| Walleye Capital LLC | $23 243 058 | 814 974 | 0,52% | Akcje |
| Point72 Asset Management, L.P. | $22 809 212 | 799 762 | 0,51% | Akcje |
| Walleye Trading LLC | $22 744 700 | 797 500 | 0,51% | Opcja kupna |
| FEDERATED HERMES, INC. | $22 241 550 | 779 858 | 0,50% | Akcje |
| Walleye Trading LLC | $20 594 292 | 722 100 | 0,46% | Opcja sprzedaży |
| Balyasny Asset Management L.P. | $20 211 240 | 708 669 | 0,45% | Akcje |
| WOLVERINE TRADING, LLC | $19 244 780 | 1 006 000 | 0,43% | Opcja kupna |
| MILLENNIUM MANAGEMENT LLC | $18 292 101 | 641 378 | 0,41% | Akcje |
| Halter Ferguson Financial Inc. | $17 882 240 | 627 007 | 0,40% | Akcje |
| CITADEL ADVISORS LLC | $17 044 921 | 597 648 | 0,38% | Akcje |
| Walleye Trading LLC | $15 952 833 | 559 356 | 0,36% | Akcje |
| Caption Management, LLC | $15 723 076 | 551 300 | 0,35% | Opcja sprzedaży |
| WOLVERINE TRADING, LLC | $14 846 793 | 776 100 | 0,33% | Opcja sprzedaży |
| CAPITAL FUND MANAGEMENT S.A. | $14 807 327 | 519 191 | 0,33% | Akcje |
| PFM Health Sciences, LP | $14 802 336 | 519 016 | 0,33% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $14 317 040 | 502 000 | 0,32% | Akcje |
| WELLS FARGO & COMPANY/MN | $14 301 981 | 501 472 | 0,32% | Akcje |
| Eurizon Capital SGR S.p.A. | $13 987 854 | 490 380 | 0,31% | Akcje |
| RPG Investment Advisory, LLC | $13 981 017 | 490 218 | 0,31% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $13 977 652 | 490 100 | 0,31% | Opcja kupna |
| Caption Management, LLC | $13 769 456 | 482 800 | 0,31% | Opcja kupna |
| Alphabet Inc. | $13 746 298 | 481 988 | 0,31% | Akcje |
| Swiss National Bank | $13 501 368 | 473 400 | 0,30% | Akcje |
| CREDIT AGRICOLE S A | $13 119 286 | 460 003 | 0,29% | Akcje |
| RBF Capital, LLC | $12 822 706 | 449 604 | 0,29% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $12 802 628 | 448 900 | 0,29% | Opcja sprzedaży |
| Trexquant Investment LP | $12 674 259 | 444 399 | 0,28% | Akcje |
| BlackRock, Inc. | $12 343 114 | 432 788 | 0,28% | Akcje |
| IMC-Chicago, LLC | $12 036 581 | 422 040 | 0,27% | Akcje |
| FORA Capital, LLC | $11 957 021 | 419 030 | 0,27% | Akcje |
| PERCEPTIVE ADVISORS LLC | $11 408 000 | 400 000 | 0,25% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $11 327 203 | 397 167 | 0,25% | Akcje |
| Rhenman & Partners Asset Management AB | $11 179 840 | 392 000 | 0,25% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $10 799 925 | 378 679 | 0,24% | Akcje |
| UBS Group AG | $10 607 358 | 371 927 | 0,24% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $10 027 661 | 351 601 | 0,22% | Akcje |
| ARDSLEY ADVISORY PARTNERS LP | $9 982 000 | 350 000 | 0,22% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $9 924 475 | 347 983 | 0,22% | Akcje |
| Fiduciary Alliance LLC | $9 802 210 | 343 696 | 0,22% | Akcje |
| BCS Private Wealth Management, Inc. | $9 665 000 | 338 885 | 0,22% | Akcje |
| SIMPLEX TRADING, LLC | $9 283 516 | 325 509 | 0,21% | Akcje |
| Squarepoint Ops LLC | $9 166 214 | 321 396 | 0,20% | Akcje |
| SEB Asset Management AB | $9 085 456 | 318 565 | 0,20% | Akcje |
| MARSHALL WACE, LLP | $9 052 762 | 317 418 | 0,20% | Akcje |
| Squarepoint Ops LLC | $8 906 796 | 312 300 | 0,20% | Opcja kupna |
| BARCLAYS PLC | $8 827 711 | 309 527 | 0,20% | Akcje |
| Engineers Gate Manager LP | $8 802 185 | 308 632 | 0,20% | Akcje |
| TOWLE & CO | $8 801 186 | 308 597 | 0,20% | Akcje |
| RHUMBLINE ADVISERS | $8 563 598 | 300 267 | 0,19% | Akcje |
| PRUDENTIAL FINANCIAL INC | $8 412 544 | 294 970 | 0,19% | Akcje |
| FIRST TRUST ADVISORS LP | $8 152 727 | 285 860 | 0,18% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $7 939 968 | 278 400 | 0,18% | Opcja kupna |
| FRED ALGER MANAGEMENT, LLC | $7 777 290 | 272 696 | 0,17% | Akcje |
| TORONTO DOMINION BANK | $7 632 066 | 267 604 | 0,17% | Akcje |
| BANK OF MONTREAL /CAN/ | $7 383 828 | 258 900 | 0,16% | Opcja sprzedaży |
| General Equity Holdings LP | $6 844 800 | 240 000 | 0,15% | Akcje |
| TD Asset Management Inc | $6 561 311 | 230 060 | 0,15% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $6 509 690 | 228 250 | 0,15% | Akcje |
| OSAIC HOLDINGS, INC. | $6 398 318 | 224 346 | 0,14% | Akcje |
| AMERIPRISE FINANCIAL INC | $6 363 383 | 223 120 | 0,14% | Akcje |
| Squarepoint Ops LLC | $6 203 100 | 217 500 | 0,14% | Opcja sprzedaży |
| Public Sector Pension Investment Board | $6 120 392 | 214 600 | 0,14% | Akcje |
| Bridgewater Associates, LP | $6 094 838 | 213 704 | 0,14% | Akcje |
| NORGES BANK | $5 741 390 | 201 311 | 0,13% | Akcje |
Insiderzy spółki 21 insiderów · 10 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark T Bertolini | Chief Executive Officer | 30 czerwca 2026 S | 7 751 570 | 1 | 8 | $-58 759 399 |
| Richard Scott Blackley | Chief Financial Officer | 2 czerwca 2026 S | 1 074 977 | 0 | 1 | $-493 628 |
| Janet Liang | President, Oscar Insurance | 2 czerwca 2026 S | 259 057 | 0 | 1 | $-194 356 |
| Meghan V. Joyce | Chief Operating Officer | 1 września 2021 M | 34 669 | 0 | 0 | $0 |
| Victoria Baltrus | Chief Accounting Officer | 2 czerwca 2026 S | 214 589 | 0 | 1 | $-23 718 |
| Adam Mcananey | Chief Legal Officer | 2 czerwca 2026 S | 218 096 | 0 | 1 | $-153 593 |
| Joshua Kushner | Co-Founder and Vice Chairman | 21 listopada 2024 P | 6 343 617 | 0 | 0 | $0 |
| Dennis Weaver | Chief Clinical Officer | 1 września 2021 M | 5 323 | 0 | 0 | $0 |
| Alessandrea C. Quane | EVP, Chief Insurance Officer | 31 sierpnia 2021 A | — | 0 | 0 | $0 |
| Joel Klein | Chief Policy & Strat. Officer | 5 marca 2021 A | 0 | 0 | 0 | $0 |
| William Gassen | Dyrektor | 9 lipca 2026 A | 82 840 | 0 | 0 | $0 |
| David Plouffe | Dyrektor | 9 lipca 2026 A | 137 121 | 0 | 0 | $0 |
| Sid Sankaran | Dyrektor | 9 lipca 2026 A | 22 609 | 0 | 0 | $0 |
| Mario Schlosser | Dyrektor | 1 lipca 2026 C | 0 | 0 | 16 | $-32 199 014 |
| Laura W Lang | Dyrektor | 4 czerwca 2026 A | 82 840 | 0 | 0 | $0 |
| Vanessa Ames Wittman | Dyrektor | 4 czerwca 2026 A | 137 121 | 0 | 0 | $0 |
| Jeffery H Boyd | Dyrektor | 9 kwietnia 2026 A | — | 0 | 0 | $0 |
| Elbert O. Robinson Jr. | Dyrektor | 5 marca 2021 A | 50 000 | 0 | 0 | $0 |
| Teri List-Stoll | Dyrektor | 5 marca 2021 A | 50 000 | 0 | 0 | $0 |
| Jr Charles E Phillips | Dyrektor | 5 marca 2021 A | 50 000 | 0 | 0 | $0 |
| Ari Fischel | — | 5 marca 2021 A | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 zgłoszenia | 13 listopada 2024 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 65 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| HEAL · Global X Funds | 4,61% | 51 902 NS | 31 maja 2026 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 3,73% | 2 476 NS | 30 kwietnia 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2,79% | 80 448 NS | 30 kwietnia 2026 | N-PORT |
| CBSE · Elevation Series Trust | 2,79% | 72 369 NS | 30 kwietnia 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,80% | 159 618 SH | 8 sierpnia 2026 | Dziennie |
| RNIN · EA Series Trust | 1,77% | 146 523 NS | 30 kwietnia 2026 | N-PORT |
| IAK · iShares Trust | 0,63% | 132 150 SH | 8 sierpnia 2026 | Dziennie |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,53% | 6 454 468 NS | 31 maja 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0,48% | 132 126 NS | 31 maja 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,40% | 258 034 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,40% | 2 189 278 SH | 8 sierpnia 2026 | Dziennie |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,37% | 59 569 SH | 8 sierpnia 2026 | Dziennie |
| OASC · Unified Series Trust | 0,25% | 9 324 NS | 31 maja 2026 | N-PORT |
| DFVE · DoubleLine ETF Trust | 0,22% | 5 265 NS | 31 marca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,21% | 1 387 125 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,20% | 6 138 237 SH | 8 sierpnia 2026 | Dziennie |
| VBK · VANGUARD INDEX FUNDS | 0,19% | 3 171 535 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,19% | 70 748 SH | 8 sierpnia 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 74 299 NS | 30 kwietnia 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 7 801 NS | 30 kwietnia 2026 | N-PORT |
| SMLF · iShares Trust | 0,18% | 282 874 SH | 8 sierpnia 2026 | Dziennie |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,18% | 99 887 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,15% | 154 382 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,11% | 87 779 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,11% | 9 555 NS | 31 maja 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,11% | 798 894 NS | 30 kwietnia 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,10% | 1 045 927 NS | 31 maja 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,10% | 576 130 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,09% | 10 063 SH | 8 sierpnia 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 60 366 NS | 30 kwietnia 2026 | N-PORT |
| ESML · iShares Trust | 0,09% | 96 699 SH | 8 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,08% | 5 488 922 SH | 8 sierpnia 2026 | Dziennie |
| VFH · VANGUARD WORLD FUND | 0,08% | 384 466 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 2 534 194 SH | 8 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,07% | 7 474 NS | 31 maja 2026 | N-PORT |
| WSML · iShares Trust | 0,06% | 14 478 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,05% | 7 563 NS | 31 maja 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 5 330 NS | 31 maja 2026 | N-PORT |
| FNCL · FIDELITY COVINGTON TRUST | 0,04% | 52 605 NS | 30 kwietnia 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,04% | 169 NS | 31 maja 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,04% | 9 312 NS | 30 kwietnia 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 12 030 SH | 8 sierpnia 2026 | Dziennie |
| TILT · FlexShares Trust | 0,03% | 38 192 NS | 30 kwietnia 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,03% | 8 235 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,03% | 164 245 NS | 31 maja 2026 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0,03% | 103 995 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 7 591 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 190 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 416 676 NS | 30 kwietnia 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 18 514 NS | 30 kwietnia 2026 | N-PORT |